ACTUATE THERAPEUTICS, INC. (ACTU)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 4, 2025 | CORRESP | Neutral/Informational | Moderate | Actuate Therapeutics, Inc. has formally withdrawn its previous request to accelerate the effective date of its registration statement to September 4, 2025, and is now requesting t… | Read Filing EDGAR |
| Sep. 2, 2025 | CORRESP | Neutral/Informational | Moderate | Actuate Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their registration statement on Form S-3 to September 4, 2025. The company acknow… | Read Filing EDGAR |
| Aug. 26, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Actuate Therapeutics, Inc. that it does not intend to review their Draft Registration Statement on Form S-3 submitted on August 18, 2025. The SEC has r… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Moderate | Actuate Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their registration statement on Form S-1 to August 4, 2025. This request is made … | Read Filing EDGAR |
| Jul. 31, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence informs Actuate Therapeutics, Inc. that their registration statement on Form S-1, filed on July 25, 2025, has not been reviewed and will not be reviewed by … | Read Filing EDGAR |